We are excited to announce that the NRG Oncology Biospecimen Bank (USA) will adopt OpenSpecimen as their biobanking LIMS.
NRG biobank is a part of a large cancer clinical trial consortium. The project involves biobanking LIMS implementation and a large legacy data migration for the UCSF and University of Pittsburgh collections.
We are delighted to have them on board and look forward to working with them.
Click here to see our full customer list.